 Home > Active Ingredient News > Digestive System Information > Big variety of 5 billion injections, Beite, Poinsettia...4 reviews on the same day

Big variety of 5 billion injections, Beite, Poinsettia...4 reviews on the same day

 Last Update: 2021-06-03
 Source: Internet
 Author: User

Tags

new stereo

treatment duodenal ulcer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, the NMPA official website released the latest batch of drug approval information, and another company passed the consistency evaluation of omeprazole sodium for injection.

Figure 1: The latest review of enterprises with Omeprazole Sodium for Injection

Source: NMPA official website

Omeprazole is the world's first approved proton pump inhibitor.

Figure 2: The share of TOP5 companies in Omeprazole Sodium for Injection in 2020

Source: Mi Nei.

In 2020, in China's public medical institutions, Osaikon will occupy more than 40% of the market share of Omeprazole Sodium for injection.

As of now, in addition to Omeprazole Sodium for injection, the companies that have reviewed omeprazole sodium include Shandong Luoxin Pharmaceutical, Shandong New Times Pharmaceutical, Guangzhou Poinsettia Pharmaceutical, Hainan Beite Pharmaceutical, Hunan Kelun Pharmaceutical, and Hunan Saican.

Table 1: Sales and national procurement of PPI injections

Source: Mi Nei.

At present, among the best-selling PPI injections in public medical institutions in China, pantoprazole, esomeprazole (esomeprazole) and lansoprazole have been included in the national procurement, and there are no companies for rabeprazole injections.

Source: NMPA official website, Mi Nei.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.